Oxcarbazepine Tablet, Film Coated
Product Images NDC 50268-679

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 50268-679). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 (679 15)

This is a description of a medication called Oxcarbazepine. It comes in the form of tablets, which are only available through prescription. The tablets come in a unit dose of 50 (5x10). The details of the medication such as quantity, instructions, etc., are not given clearly. The text also contains some random characters and codes, and therefore, the information provided is not very useful.*

FDA Label Image

50 (680 15)

This is a description for Oxcarbazepine tablets, USP which come in 300mg tablets. This drug is available only via prescription with a quantity of 50 tablets in a package containing 5 unit dose packets of 10 tablets each. It has National Drug Code (NDC) 50268.680-15 and the LT code 0268 68015. The text contains information regarding its origin (PAHACT D e Mot i prvided s o.), manufacturer's packaging (Comgespocage s st 2G50 6 b 7 st 1500 DT GFin 157 on U5 ol o), and mentions of OFPEAGH OF CALEREL and Venstcarsd o. The last line is not readable.*

FDA Label Image

50 (681 15)

This is a medication called Oxcarbazepine in tablet form that is only available with a prescription. The packaging contains 50 tablets with 5 or 10 in each unit dose. There is a product identification number of 5026868115 and a website mentioned that may or may not relate to the product (PAHACIST Dot, Maicaten Gs). Other text is not readable.*

FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)

The log-rank test was performed with a resulting p-value of 0.0001. The text also includes a table showing time on trial from Day 2 to Day 11 for each treatment group. The treatment group is Oxcarbarspine.*

FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)

FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)

This appears to be the results of a log-rank test, with a p-value of 0.0001. There is also a chart with numbers ranging from 10 to 130 and a treatment group labeled as "HIGH-LOW" with a measure of "Time to exit (days)".*

FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)

The text represents statistical analysis results of a medical treatment. Specifically, it indicates the p-value of a log-rank test and a graph presenting the time to exit in days for two different treatment groups labeled as "HIGH" and "LOW". However, the quality is not high making it difficult to confirm the context with certainty.*

FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepinetabstruct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.